Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009.
du Plessis
Mignon
M
de Gouveia
Linda
L
Skosana
Happy
H
Thomas
Juno
J
Blumberg
Lucille
L
Klugman
Keith P
KP
von Gottberg
Anne
A
D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000235:genetics; D002443:Ceftriaxone / Q000627:therapeutic use; D027081:DNA Gyrase / Q000235:genetics; D027101:DNA Topoisomerase IV / Q000235:genetics; D024881:Drug Resistance, Bacterial; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D008585:Meningitis, Meningococcal / Q000188:drug therapy / Q000382:microbiology; D008826:Microbial Sensitivity Tests; D009345:Neisseria meningitidis / Q000187:drug effects* / Q000302:isolation & purification; D017422:Sequence Analysis, DNA; D013019:South Africa; D014195:Travel
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D024841:Fluoroquinolones; D002443:Ceftriaxone; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase